Central nervous system (CNS) toxoplasmosis is the most common cause of cere
bral mass lesions in AIDS patients. Toxoplasma gondii is commonly acquired
through ingestion of contaminated meats resulting in latent infection. With
the onset of immunosuppression, it may preferentially infect the CNS, resu
lting in a wide range of clinical presentations. Effective antibiotic thera
py is available and capable of producing rapid remission of active infectio
n but must be continued throughout life to prevent recurrence. Characterist
ic presentations and rapid therapeutic response permit presumptive diagnosi
s and initiation of specific antibiotics in many cases; however, appropriat
e clinical and radiographic monitoring to detect alternative or mixed patho
logies is necessary. Unusual presentations may hinder rapid diagnosis and s
hould be considered in AIDS patients with cryptic CNS symptoms. Despite inc
reasing attention to primary prophylaxis, the worldwide distribution of thi
s parasite, its potential to be the presenting illness in previously uniden
tified human immunodeficiency virus-infected individuals, and failures of p
rophylaxis are likely to make toxoplasmosis an important continuing source
of neurologic morbidity in AIDS.